GlaxoSmithKline Pharmaceuticals informs about closure of trading window

Glaxosmithkline Pharmaceuticals Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 500660 | NSE: GLAXO

27 Jun 2024 Evaluate

In terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, GlaxoSmithKline Pharmaceuticals has informed that the trading period for buying or selling of Company's shares is closed from Monday, 1st July 2024 and shall reopen on Wednesday, 7th August 2024 after the approval & declaration of Un-Audited financial results for first quarter ended 30th June 2024 by the Board of Directors at its meeting scheduled to be held on Friday, 2nd August 2024.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1852.50
Dr. Reddys Labs.	1146.30
Cipla	1360.10
Lupin	2047.00
Zydus Lifesciences	1108.50
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.